1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Anbc, Inc.

Anbc, Inc.

SYUP
Anbc, Inc.US flagOther OTC
0.00
USD
- -
- -
15,921.00Market Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
Jiang-an Lu
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
No 2020 Huqingping Road Shanghai SH People's Republic of China 201702
IPO Date
Jul 24, 2009
Website
anbc.com
Similar Companies
RIV Capital Inc. (CNPOF)
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)
Mydecine Innovations Group Inc. (MYCO.NE)
Poko Innovations Inc. (POKO.CN)
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY)
Divi's Laboratories Limited (DIVISLAB.BO)
Business
ANBC, Inc. (SYUP) manufactures and processes healthcare and nutraceutical products through its subsidiary Shanghai New Bei Le Biotechnology Co., Ltd., operating a good manufacturing practices (GMP) compliant nutraceutical processing and packaging plant in Shanghai, China. The company produces capsules, food additives, and nutraceutical items including Qilisheng; it sells these products on a wholesale basis to distributors, with primary operations focused on the Chinese market. Founded in 2006 and headquartered at No 2020 Huqingping Road, Qingpu District, Shanghai, China 201702, ANBC, Inc. engages in food circulation activities alongside its core healthcare product manufacturing. No major acquisitions, partnerships, funding rounds, product launches, or strategic shifts have been publicly reported for ANBC, Inc. in the last 1-2 years, with the company maintaining its established nutraceutical focus amid minimal recent news coverage.